Season 01: Episode 77
In this episode, GOLD talks to Catherine Owen, Head of Major Markets at Bristol Myers Squibb, who discusses her path into the pharmaceutical industry and the upcoming changes to its data policies. Catherine explores the collection and storage of data, how we can ensure data systems are in place for the next pandemic, methods to build a new data culture and her key takeaways from the past year in pharma.
A little more on GOLD’s guest…
Catherine Owen joined Bristol-Myers Squibb in 2019, in the midst of the merger between BMS and Celgene. She oversees operations in 19 key global markets, and covers BMS’ portfolio of prescription medicines in haematology, oncology, immunology and cardiovascular. She has over 20 years of leadership experience, having worked for other companies such as AstraZeneca and Janssen. She has a degree in pharmacy from the University of Manchester, along with a post-graduate degree in marketing from the University of London. She is enthusiastic about developing people both professionally and personally and, in 2018, received the Healthcare Businesswomen’s Association Luminary award.
Topics covered
- Data collection and storage
- Government guidelines
- Diversifying staff
- European healthcare
- HTA submissions
